Our AI technology, DERM is now a Class IIa UKCA certified medical device. This clearance allows Skin Analytics to continue to innovate skin cancer pathways with our partners. This is the next step for Skin Analytics and our technology but it is by no means the end. We will continue to work with regulators as standards of AI in clinical pathways evolve and develop, driving towards clinical excellence.
Categories
Recent Posts
- Skin Analytics achieves Class IIa UKCA Mark for DERM. The UK’s first and only Class IIa certified AI dermatology device
- The Story So Far…
- Discussing the systematic review of skin cancer datasets in The Lancet: Skin Analytics response.
- Skin Analytics Receives NHSX Award for AI-Based Skin Cancer Tool
- Google’s move into skin cancer analysis is great news for patients and Skin Analytics